These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10632304)

  • 1. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Vandenbroucke JP
    Arch Intern Med; 2000 Jan; 160(1):49-52. PubMed ID: 10632304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis.
    Martinelli I; Taioli E; Bucciarelli P; Akhavan S; Mannucci PM
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):700-3. PubMed ID: 10073976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias.
    Bloemenkamp KW; Rosendaal FR; Büller HR; Helmerhorst FM; Colly LP; Vandenbroucke JP
    Arch Intern Med; 1999 Jan; 159(1):65-70. PubMed ID: 9892332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?
    Spannagl M; Heinemann LA; Schramm W
    Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):105-12. PubMed ID: 10943572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
    Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
    Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
    Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
    Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thrombosis, oral contraceptives and high factor VIII levels.
    Bloemenkamp KW; Helmerhorst FM; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1999 Sep; 82(3):1024-7. PubMed ID: 10494758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in young female while on oral contraceptives: high frequency of inherited thrombophilia and analysis of thrombotic events in 400 czech women.
    Dulícek P; Malý J; Pecka M; Beránek M; Cermáková E; Malý R
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):567-73. PubMed ID: 19117968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk.
    Vayá A; Mira Y; Mateo J; Falco C; Villa P; Estelles A; Corella D; Fontcuberta J; Aznar J
    Thromb Haemost; 2003 Mar; 89(3):452-7. PubMed ID: 12624627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilias and gynaecology.
    Bloemenkamp KW; Helmerhorst FM; Rosendaal FR; Vandenbroucke JP
    Best Pract Res Clin Obstet Gynaecol; 2003 Jun; 17(3):509-28. PubMed ID: 12787541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.
    Pomp ER; le Cessie S; Rosendaal FR; Doggen CJ
    Br J Haematol; 2007 Oct; 139(2):289-96. PubMed ID: 17897305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank.
    Lo Faro V; Johansson T; Johansson Å
    Am J Obstet Gynecol; 2024 Mar; 230(3):360.e1-360.e13. PubMed ID: 37734636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group.
    de Bruijn SF; Stam J; Koopman MM; Vandenbroucke JP
    BMJ; 1998 Feb; 316(7131):589-92. PubMed ID: 9518910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
    Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR
    BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.